Status:

COMPLETED

Perioperative Care of HVPG Measurement (CHESS1904): An International Multicenter Survey

Lead Sponsor:

Hepatopancreatobiliary Surgery Institute of Gansu Province

Collaborating Sponsors:

LanZhou University

Shandong Provincial Hospital

Conditions:

Portal Hypertension

Cirrhosis, Liver

Eligibility:

All Genders

18-75 years

Brief Summary

Hepatic venous pressure gradient (HVPG) is an invasive test and requires technical skills of the operator and specialized instruments. HVPG measurement and anesthesia can cause stress responses in the...

Detailed Description

Portal hypertension is an important factor affecting the clinical outcomes of cirrhosis patients, and its severity determines the occurrence of development of cirrhosis complications, such as rupture ...

Eligibility Criteria

Inclusion

  • Eligible participants must meet the following criteria:
  • aged between 18-75 years, no restriction on gender;
  • clinically and/or pathologically diagnosed sinusoidal cirrhosis;
  • with written informed consent
  • scheduled to undergo HVPG measurement according to the following indications: 1) assessment of the efficacy of primary and secondary prophylactic drugs for gastroesophageal variceal bleeding; 2) predicting the risk of gastroesophageal variceal bleeding and guiding the selection of the treatment regimens; 3) predicting of risk, progression, and clinical outcomes of decompensation events in cirrhosis; 4) evaluation of the efficacy of new drugs; 5) evaluation of the accuracy of new non-invasive techniques; diagnosis and differential diagnosis of types of portal hypertension.

Exclusion

  • Those cases that meet any of the following criteria should be excluded:
  • contradictions for HVPG measurement;
  • pregnant or lactating woman;
  • severe coagulopathy (international normalized ratio\>5);
  • severe heart, lung, or kidney disease.

Key Trial Info

Start Date :

October 16 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2022

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04121520

Start Date

October 16 2019

End Date

August 1 2022

Last Update

April 25 2023

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Universidade Federal de Pernambuco

Recife, Brazil

2

The First Hospital of Lanzhou University

Lanzhou, Gansu, China

3

Xingtai People's Hospital

Xingtai, Hebei, China

4

Shandong Provincial Hospital affiliated to Shandong University

Jinan, Shandong, China